This is a routine insider sale following option exercise, not a secondary offering. The dollar amount is small relative to market cap. Monitor for any pattern of repeated insider selling that could signal management's view on valuation.
RVMD drugs
RVMD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 12 $176.35entry
- T+1 · 4d ago −2.30%α −1.94% · $172.29
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Jack Anders, an officer of Revolution Medicines, filed a Form 144 notice to sell 35,750 shares of common stock with an estimated aggregate market value of approximately $6.9 million. The shares were acquired through the exercise of stock options on November 11, 2026, and the sale was executed on the same day. The filing was delayed by one day due to the Veterans Day federal holiday.
Key Facts
- Reporting person: Jack Anders, an officer of Revolution Medicines, Inc.
- Securities to be sold: 35,750 shares of common stock
- Estimated aggregate market value: approximately $6,901,895
- Shares acquired on November 11, 2026 via exercise of stock options from the issuer
- Sale executed on November 11, 2026; filing submitted on November 12, 2026 due to federal holiday
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Financial Impact
Sale of 35,750 shares valued at ~$6.9 million, representing approximately 0.017% of the company's $41.8B market cap
Risk Factors
- Insider sale may signal reduced conviction if repeated or increased in size
- Form 144 is an intent to sell; the actual sale may not occur if market conditions change
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010979 |
| Document: 0001950047-26-010979-index.html | 0001950047-26-010979 |
| Document: 0001950047-26-010979.txt | 0001950047-26-010979 |
Track record
44 reports on RVMD
7 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +31.56% at T+60 after the Apr 21, 2026 report. 17 of 18 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $167.00 Now $166.87 −0.08% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $168.20 Now $166.87 −0.79% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $176.02 Now $166.87 −5.20% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 3/10 Viewing Entry $176.35 Now $166.87 −5.38% settles Feb 10
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Nov 4, 202612d ago 8-K Bullish 7/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $191.31 Now $166.87 −12.78% settles Jan 28
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $186.99 Now $166.87 −10.76% settles Jan 21
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $187.69 Now $166.87 −11.09% settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers